Meda is a leading international specialty pharma company with a broad product portfolio reaching more than 80% of the global pharmaceutical market. Sales at the end of 2014 amounted to more than SEK 15 billion (pro forma SEK 18.7 billion). Meda is thereby the 48th largest pharmaceutical company in the world.
At the end of 2014 Meda had 5,202 (3,326) employees, 2,996 (2,009) of which worked in sales and marketing. The company’s main focus is sales and marketing and Meda has its own sales organizations in more than 60 countries. Sales and marketing activities are carried out via distributors in countries where Meda has no representation and globally Meda’s products are sold in more than 150 countries.
Meda in the US is headquartered in Somerset, New Jersey.
This analysis indicates that Meda in the US is a substantial player in the global pharmaceutical market, with an extensive product portfolio and significant sales. The company's strong focus on sales and marketing, with a presence in over 60 countries, reflects a robust business strategy. Moreover, being headquartered in Somerset, New Jersey, provides strategic positioning within the prominent pharmaceutical industry locale.
